EPS Bio Technology Corp. (TPEX:4183)
Taiwan · Delayed Price · Currency is TWD 13.00
-0.05 (-0.38%)
May 29, 2026, 1:00 PM CST
EPS Bio Technology Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 309 | 395 | 552 | 630 | 440 | 438 | |
Market Cap Growth | -44.44% | -28.45% | -12.29% | 42.97% | 0.54% | -14.02% |
Enterprise Value | 351 | 387 | 512 | 568 | 407 | 400 |
Last Close Price | 13.00 | 16.60 | 22.41 | 24.79 | 16.52 | 15.79 |
PE Ratio | - | - | 31.90 | 29.99 | 17.36 | 23.50 |
PS Ratio | 0.70 | 0.79 | 1.22 | 1.34 | 0.95 | 0.91 |
PB Ratio | 1.15 | 1.41 | 1.81 | 2.06 | 1.43 | 1.46 |
P/TBV Ratio | 1.16 | 1.42 | 1.82 | 2.07 | 1.45 | 1.49 |
P/FCF Ratio | - | - | - | 13.78 | - | 21.53 |
P/OCF Ratio | - | 655.19 | - | 11.41 | 88.10 | 13.65 |
EV/Sales Ratio | 0.79 | 0.78 | 1.14 | 1.21 | 0.88 | 0.83 |
EV/EBITDA Ratio | - | 169.87 | 32.72 | 15.81 | 14.18 | 8.51 |
EV/EBIT Ratio | - | - | 94.89 | 22.78 | 25.44 | 12.10 |
EV/FCF Ratio | -7.71 | - | - | 12.42 | - | 19.67 |
Debt / Equity Ratio | 0.51 | 0.50 | 0.36 | 0.38 | 0.39 | 0.42 |
Debt / EBITDA Ratio | - | 23.40 | 5.63 | 2.91 | 3.72 | 2.48 |
Debt / FCF Ratio | - | - | - | 2.54 | - | 6.22 |
Net Debt / Equity Ratio | 0.15 | 0.06 | -0.06 | -0.26 | -0.19 | -0.26 |
Net Debt / EBITDA Ratio | -5.39 | 7.75 | -1.20 | -2.21 | -1.99 | -1.64 |
Net Debt / FCF Ratio | -0.91 | -0.81 | 0.41 | -1.74 | 5.75 | -3.78 |
Asset Turnover | - | 0.93 | 0.83 | 0.88 | 0.84 | 0.85 |
Inventory Turnover | - | 5.35 | 4.62 | 4.46 | 4.24 | 5.50 |
Quick Ratio | 1.69 | 1.81 | 2.18 | 2.32 | 2.51 | 1.96 |
Current Ratio | 2.43 | 2.30 | 2.83 | 2.93 | 3.37 | 2.50 |
Return on Equity (ROE) | - | -2.69% | 5.67% | 6.83% | 8.35% | 6.13% |
Return on Assets (ROA) | - | -1.06% | 0.62% | 2.91% | 1.81% | 3.67% |
Return on Invested Capital (ROIC) | -6.48% | -3.11% | 2.05% | 8.28% | 6.25% | 11.87% |
Return on Capital Employed (ROCE) | -5.40% | -2.40% | 1.30% | 6.00% | 3.80% | 7.90% |
Earnings Yield | -6.90% | -1.99% | 3.13% | 3.33% | 5.76% | 4.26% |
FCF Yield | -14.70% | -5.51% | -8.37% | 7.26% | -2.26% | 4.64% |
Dividend Yield | 5.13% | - | 2.99% | 3.23% | 5.93% | 4.43% |
Payout Ratio | - | - | 110.01% | 111.13% | 65.69% | 153.23% |
Buyback Yield / Dilution | - | 0.23% | 0.08% | 0.10% | -0.03% | 0.13% |
Total Shareholder Return | 5.13% | 0.23% | 3.07% | 3.33% | 5.91% | 4.56% |